Tachycardia-Induced Cardiomyopathy

Czech version

Authors: A. Andrášová; V. Bufka; R. Jirmář; P. Gregor
Authors‘ workplace: Kardiocentrum 3. LF UK a FNKV, Praha
Published in: Čas. Lék. čes. 2007; 146: 878-881
Category: Case Report

Overview

Tachycardia-induced cardiomyopathy is characterised with a ventricular dysfunction caused by increased ventricular rate. It is a reversible mechanism of the heart failure. Cardiomyopathy can recover after the restoration of sinus–rhythm or after adjusting the heart rate. In the presented paper we are discussing ethiopathogenesis, diagnostics and therapy of tachycardia-induced cardiomyopathy and we are describing the case of a patient with this diagnosis, who was admitted to our department.

Key words:
tachycardia, cardiomyopathy, heart failure.

Labels

Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management Dental Hygienist

The Importance of Screening for Thyroid Dysfunction During Pregnancy: Pathophysiological Background and Practical Implications

Reflection on the Physiological Mechanisms of Movements Controlled by the Spinal Cord – Brain Interaction

Nutrigenetics and Nutrigenomics

The Interpreter Role of Clinical Geneticist in the Process of Genetic Testing

Silent Ischemia and Noisy Stunning: A Perspective of the Cause and Hints of Associations

Thromboembolism in Pregnancy – Physiology and Pathophysiology of Hemocoagulation Changes During Normal and Pathological Gravidity

Milestones of Cardiovascular Therapy. V. Diuretics

Significance of Serum Antibodies ANCA, ASCA, ABBA in Diagnostics of Idiopathic Intestinal Inflammations

Pilot Study to Evaluate Blood Glucose Control by a Model Predictive Control Algorithm with Variable Sampling Rate vs. Routine Glucose Management Protocol in Peri- and Postoperative Period in Cardiac Surgery Patients

Changes of Plasminogen Activator Inhibitor (PAI-1) During Estrogen Replacement Therapy

Repeated Thrombosis of the Mechanical Heart Valve Prosthesis

Article was published in

Journal of Czech Physicians

2007 Issue 11

Download issue PDF